Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Georgiadou SP, Lewis RE, Best L, Torres HA, Champlin RE . The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary profylaxis. Bone Marrow Transplant 2013; 48: 141–143.

    Article  CAS  Google Scholar 

  2. Vehreschild JJ, Sieniawski M, Reuter S, Arenz D, Reichert D, Maertens J et al. Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from multinational case registry. Int J Antimicrob Agents 2009; 34: 446–450.

    Article  CAS  Google Scholar 

  3. Zhang P, Song A, Wang S, Feng S, Qiu L, Han M . Hematopoietic SCT in patients with history of invasive fungal infection. Bone Marrow Transplant 2009; 43: 533–537.

    Article  CAS  Google Scholar 

  4. Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the EGIL3 -2009 update. Bone Marrow Transplantation 2011; 46: 709–718.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U Salmenniemi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salmenniemi, U., Remes, K. & Itälä-Remes, M. Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection. Bone Marrow Transplant 48, 1262–1263 (2013). https://doi.org/10.1038/bmt.2013.45

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.45

Search

Quick links